Filter by: Subject

Filter by: Subject

Results Per Page:

Children who are HIV-exposed-but-uninfected (CHEU) (1)
Children who are HIV-unexposed–and-uninfected (CHUU) (1)
Chronic kidney disease (1)
Combination antiretroviral therapy (cART) (1)
Community-acquired bacterial pneumonia (1)
Drug resistance (1)
Drug safety (1)
Dysbiosis (1)
Eutrophil-platelet aggregates (1)
Food security (1)
Growth (1)
Hepatitis-C virus (1)
Highly active antiretroviral therapy (1)
HIV drug resistance (1)
HIV infected patients (1)
HIV-1 (1)
HIV-exposed (1)
HIV-exposed, but uninfected (HEU) (1)
HIV-infection (1)
Immune activation (1)
Immunosuppression (1)
Infants (1)
Infected children (1)
Innate immunity (1)
Interleukin-6 (1)
Lymphoid fibrosis (1)
Macrophage activation (1)
Macrophages (1)
Metabolic changes (1)
Microbial translocation (1)
Monocytes (1)
Mortality (1)
multi (1)
Multidrug-resistant virus (1)
Myocardial infarction (1)
Neonates (1)
Neurodevelopment (1)
Neutrophils (1)
NiO/activated carbon (AC) (1)
Non-AIDS defining disorders (1)
Non-AIDS-defining disorders (1)
Non-AIDSdefining defining disorders (1)
Nutrition (1)
Obstructive pulmonary disease (1)
Organ fibrosis (1)
Paediatric HIV cure research (1)
Persistence (1)
Pilot study (1)
Plasma (1)
Platelet-derived growth factor BB (1)
Pregnancy (1)
Regulatory T-cells (1)
SDG-03: Good health and well-being (1)
Smoking (1)
Soluble CD40 ligand (1)
Soluble CD62P (1)
Sub-Saharan Africa (1)
T Regulatory cells (1)
Transforming growth factor-β1 (TGF-β1) (1)
Translocation (genetics) (1)
Undisclosed prior treatment (1)
Vaccination (1)
Women living with HIV (WLHIV) (1)